Truvada
Product Images NDC 67296-1237

1 FDA label image from Redpharm Drug, Inc. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 1 technical images submitted to the FDA as part of the official labeling for Truvada (NDC 67296-1237). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Redpharm Drug, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Truvada 200/300mg (Doc20170511113329 001)

Truvada 200/300mg (Doc20170511113329 001)
Two packaging labels for Truvada 200/300 MG tablets are shown, each indicating prescription use only. One label is for a 4-tablet package with lot number 004681 1 and expiration date 03/19. The other is for a 3-tablet package with lot number 005827 1 and expiration date 08/19. Both labels state to see package insert for dosage and storage at 20-25°C. Manufactured for Gilead Sciences Inc., distributed by RedPharm Drug, Eden Prairie, MN.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.